GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 90 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,838,000 | +157.1% | 294,749 | +215.7% | 0.10% | +146.3% |
| Q2 2017 | $1,104,000 | -7.8% | 93,349 | 0.0% | 0.04% | -10.9% |
| Q1 2017 | $1,197,000 | +4.7% | 93,349 | 0.0% | 0.05% | -6.1% |
| Q4 2016 | $1,143,000 | +3.7% | 93,349 | 0.0% | 0.05% | +16.7% |
| Q3 2016 | $1,102,000 | +35.7% | 93,349 | 0.0% | 0.04% | +27.3% |
| Q2 2016 | $812,000 | +65.0% | 93,349 | 0.0% | 0.03% | +57.1% |
| Q1 2016 | $492,000 | -32.0% | 93,349 | 0.0% | 0.02% | -19.2% |
| Q4 2015 | $724,000 | -57.2% | 93,349 | -56.6% | 0.03% | -57.4% |
| Q3 2015 | $1,693,000 | -13.1% | 215,149 | 0.0% | 0.06% | -14.1% |
| Q2 2015 | $1,949,000 | – | 215,149 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|